Principal Financial Group Inc Bio Techne Corp Transaction History

Principal Financial Group Inc

$162 Billion
Q1 2024

A detailed history of Principal Financial Group Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Principal Financial Group Inc holds 264,522 shares of TECH stock, worth $18.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

264,522

Previous 265,387 0.33%

Holding current value

$18.9 Million

Previous $20.5 Million 9.07%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$65.98 - $77.09 $57,072 - $66,682	-865 Reduced 0.33%	264,522 $18.6 Million
Q4 2023 Feb 07, 2024	SELL	$52.83 - $78.22 $117,810 - $174,430	-2,230 Reduced 0.83%	265,387 $20.5 Million
Q3 2023 Nov 02, 2023	BUY	$67.52 - $89.42 $86,425 - $114,457	1,280 Added 0.48%	267,617 $18.2 Million
Q2 2023 Aug 07, 2023	SELL	$73.76 - $85.98 $1.5 Million - $1.75 Million	-20,323 Reduced 7.09%	266,337 $21.7 Million
Q1 2023 May 09, 2023	BUY	$71.62 - $86.62 $404,796 - $489,576	5,652 Added 2.01%	286,660 $21.3 Million

Q4 2022 Feb 09, 2023	BUY	$80.67 - $352.29 $17.1 Million - $74.6 Million	211,852 Added 306.34%	281,008 $23.3 Million
Q3 2022 Nov 09, 2022	SELL	$282.54 - $391.85 $4.03 Million - $5.59 Million	-14,270 Reduced 17.1%	69,156 $19.6 Million
Q2 2022 Aug 10, 2022	SELL	$322.67 - $449.65 $706,647 - $984,733	-2,190 Reduced 2.56%	83,426 $28.9 Million
Q1 2022 May 09, 2022	SELL	$353.85 - $487.79 $13.6 Million - $18.8 Million	-38,556 Reduced 31.05%	85,616 $37.1 Million
Q4 2021 Feb 09, 2022	SELL	$456.15 - $525.06 $4.86 Million - $5.6 Million	-10,659 Reduced 7.91%	124,172 $64.2 Million
Q3 2021 Nov 09, 2021	SELL	$444.87 - $538.88 $16.8 Million - $20.4 Million	-37,808 Reduced 21.9%	134,831 $65.3 Million
Q2 2021 Aug 10, 2021	SELL	$387.35 - $450.26 $163,849 - $190,459	-423 Reduced 0.24%	172,639 $77.7 Million
Q1 2021 May 10, 2021	BUY	$314.62 - $411.0 $17.8 Million - $23.2 Million	56,501 Added 48.47%	173,062 $66.1 Million
Q4 2020 Feb 08, 2021	BUY	$246.9 - $321.87 $53,824 - $70,167	218 Added 0.19%	116,561 $37 Million
Q3 2020 Nov 06, 2020	SELL	$232.22 - $282.96 $822,755 - $1 Million	-3,543 Reduced 2.96%	116,343 $28.8 Million
Q2 2020 Aug 05, 2020	BUY	$185.43 - $279.56 $449,111 - $677,094	2,422 Added 2.06%	119,886 $31.7 Million
Q1 2020 May 12, 2020	SELL	$161.17 - $221.51 $7.87 Million - $10.8 Million	-48,850 Reduced 29.37%	117,464 $22.3 Million
Q4 2019 Feb 05, 2020	BUY	$189.68 - $222.09 $37,936 - $44,418	200 Added 0.12%	166,314 $36.5 Million
Q3 2019 Nov 13, 2019	SELL	$183.56 - $216.72 $516,170 - $609,416	-2,812 Reduced 1.66%	166,114 $32.5 Million
Q2 2019 Aug 12, 2019	BUY	$188.72 - $215.43 $196,834 - $224,693	1,043 Added 0.62%	168,926 $35.2 Million
Q1 2019 May 10, 2019	BUY	$136.09 - $200.44 $127,924 - $188,413	940 Added 0.56%	167,883 $33.3 Million
Q4 2018 Feb 14, 2019	BUY	$132.75 - $203.8 $7,832 - $12,024	59 Added 0.04%	166,943 $24.2 Million
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $154,664 - $214,111	-1,049 Reduced 0.62%	166,884 $34.1 Million
Q2 2018 Aug 13, 2018	SELL	$144.9 - $165.58 $7.82 Million - $8.93 Million	-53,954 Reduced 24.32%	167,933 $0
Q1 2018 May 14, 2018	BUY	$131.46 - $151.04 $3.07 Million - $3.53 Million	23,354 Added 11.76%	221,887 $33.5 Million
Q4 2017 Feb 13, 2018	SELL	$121.17 - $134.75 $4.49 Million - $4.99 Million	-37,026 Reduced 15.72%	198,533 $25.7 Million
Q3 2017 Nov 02, 2017	BUY	$113.59 - $123.78 $26.8 Million - $29.2 Million	235,559	235,559 $28.5 Million

Others Institutions Holding TECH

# of Institutions

581

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Bio Techne Corp Transaction History